Real life experience with omalizumab in patients with poorly controlled moderate to severe asthma

被引：0
|
作者：
Ricciardi, L. [1 ]
Arena, E. [1 ]
Loschiavo, G. [1 ]
D'Angelo, A. G. [1 ]
Sinagra, F. [1 ]
Paffumi, I [1 ]
Saitta, S. [1 ]
Marotta, G. [1 ]
机构：
[1] Univ Hosp, Allergy & Clin Immunol Unit, Messina, Italy
来源：
ALLERGY | 2013年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：375 / 375
页数：1
相关论文
共 50 条
  • [21] Predictors of response to therapy with omalizumab in patients with severe allergic asthma - a real life study
    Kallieri, Maria
    Papaioannou, Andriana I.
    Papathanasiou, Evgenia
    Ntontsi, Polyxeni
    Papiris, Spyridon
    Loukides, Stelios
    POSTGRADUATE MEDICINE, 2017, 129 (06) : 598 - 604
  • [22] Effect of omalizumab treatment on asthma exacerbations? Real-life results of patients with severe uncontrolled asthma
    Havlucu, Y.
    Yorgancioglu, A.
    Kurhan, F.
    ALLERGY, 2016, 71 : 367 - 367
  • [23] Therapy with omalizumab in patients with severe persistant allergic asthma: real life data in Turkey
    Bavbek, S.
    Aydin, O.
    Ozdemir, Kepil S.
    Yilmaz, I
    Celik, G.
    Demirel, Y.
    Mungan, D.
    Sin, B.
    Kursun, N.
    Misirligil, Z.
    ALLERGY, 2011, 66 : 366 - 366
  • [24] Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany
    Korn, S.
    Thielen, A.
    Seyfried, S.
    Taube, C.
    Kornmann, O.
    Buhl, R.
    RESPIRATORY MEDICINE, 2009, 103 (11) : 1725 - 1731
  • [25] Real-life experience of Omalizumab in adult Cystic Fibrosis patients with allergic severe asthma and Allergic Bronchopulmonary Aspergillosis
    Bellocchia, Michela Maria
    Bonizzoni, Giacomo
    Biglia, Carlotta
    Bena, Cristina
    Clivati, Elisa
    Difino, Valentina
    Traversa, Fabio
    Demichelis, Sara
    Ricciardolo, Fabio Luigi Massimo
    Albera, Carlo
    Messore, Barbara
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [26] Therapy with omalizumab in patients with severe persistant allergic asthma: a real life data in Turkey
    Bavbek, Sevim
    Aydin, Omer
    Ozdemir, Secil Kepil
    Yilmaz, Insu
    Celik, Gulfem E.
    Demirel, Yavuz Selim
    Mungan, Dilsad
    Sin, Betul
    Kursun, Nazmiye
    Misirligil, Zeynep
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2010, 58 (04): : 425 - 434
  • [27] Omalizumab Responder Analysis In Chinese Patients With Moderate-To-Severe Asthma
    Li, J.
    Kang, J.
    Wang, C.
    Yang, J.
    Wang, L.
    Humphries, M.
    Greenberg, S.
    Zhong, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [28] Omalizumab adherence in an observational study of patients with moderate to severe allergic asthma
    Janson, Susan L.
    Solari, Paul G.
    Trzaskoma, Benjamin
    Chen, Hubert
    Haselkorn, Tmirah
    Zazzali, James L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 114 (06) : 516 - +
  • [29] Observational study in asthmatics patients after reduction/withdrawal of Omalizumab for good asthma control: real life experience from a Severe Asthma Unit
    Bastidas Parlanti, Jose Alessandro
    Marquez, Dorkas M.
    Bobolea, Irina
    Herraez Herrera, Lys
    Garcia Moguel, Ismael
    Rodriguez Fernandez, Consuelo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB11 - AB11
  • [30] Omalizumab Improves Quality of Life and Asthma Control in Chinese Patients With Moderate to Severe Asthma: A Randomized Phase III Study
    Li, Jing
    Kang, Jian
    Wang, Changzheng
    Yang, Jing
    Wang, Linda
    Kottakis, Ioannis
    Humphries, Michael
    Zhong, Nanshan
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2016, 8 (04) : 319 - 328
12345